CRIS Current Research Information System

VAIRA, BERARDINO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.467
AS - Asia 12.839
NA - Nord America 12.426
SA - Sud America 1.104
AF - Africa 402
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 14
Totale 41.273
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.214
IT - Italia 8.297
SG - Singapore 4.047
VN - Vietnam 3.244
CN - Cina 2.894
GB - Regno Unito 1.565
HK - Hong Kong 1.070
DE - Germania 873
BR - Brasile 856
SE - Svezia 659
NL - Olanda 583
FR - Francia 534
IN - India 449
UA - Ucraina 440
RU - Federazione Russa 430
IE - Irlanda 247
JP - Giappone 186
BD - Bangladesh 171
KR - Corea 170
FI - Finlandia 164
ZA - Sudafrica 159
BG - Bulgaria 121
CH - Svizzera 114
EE - Estonia 112
CA - Canada 106
AR - Argentina 98
JO - Giordania 96
ID - Indonesia 82
ES - Italia 73
SC - Seychelles 65
TH - Thailandia 64
PH - Filippine 61
MX - Messico 59
IQ - Iraq 54
CI - Costa d'Avorio 50
AT - Austria 42
TR - Turchia 41
PL - Polonia 40
BE - Belgio 38
EC - Ecuador 38
PK - Pakistan 37
TW - Taiwan 33
TG - Togo 27
PY - Paraguay 26
AL - Albania 25
CO - Colombia 25
GR - Grecia 24
SA - Arabia Saudita 24
MY - Malesia 19
PE - Perù 18
VE - Venezuela 17
DO - Repubblica Dominicana 16
EU - Europa 16
RO - Romania 16
EG - Egitto 15
MA - Marocco 15
UZ - Uzbekistan 14
CL - Cile 13
KE - Kenya 13
LB - Libano 13
LT - Lituania 13
AU - Australia 10
IR - Iran 10
TN - Tunisia 10
CZ - Repubblica Ceca 9
LY - Libia 9
AE - Emirati Arabi Uniti 8
IL - Israele 8
DZ - Algeria 7
PS - Palestinian Territory 7
ET - Etiopia 6
HR - Croazia 6
NG - Nigeria 6
NP - Nepal 6
AZ - Azerbaigian 5
BO - Bolivia 5
DK - Danimarca 5
GT - Guatemala 5
KZ - Kazakistan 5
PT - Portogallo 5
CR - Costa Rica 4
GA - Gabon 4
JM - Giamaica 4
NO - Norvegia 4
OM - Oman 4
RS - Serbia 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
HN - Honduras 3
LU - Lussemburgo 3
MU - Mauritius 3
NZ - Nuova Zelanda 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BH - Bahrain 2
BZ - Belize 2
Totale 41.223
Salva come PNG Salva come JPEG
Città #
Singapore 2.464
Southend 1.352
San Jose 1.205
Ashburn 1.054
Hong Kong 1.028
Santa Clara 933
Fairfield 814
Milan 807
Ho Chi Minh City 799
Chandler 673
Hanoi 658
Rome 618
Boardman 562
Woodbridge 418
Hefei 404
Wilmington 400
Bologna 392
Seattle 384
Beijing 378
Princeton 367
Houston 362
Naples 329
Jacksonville 290
Cambridge 284
Ann Arbor 249
Dong Ket 246
Dublin 246
Lauterbourg 195
Los Angeles 181
Padova 179
Turin 177
New York 174
Tokyo 162
Nanjing 160
Westminster 149
Bari 146
Seoul 141
Helsinki 138
Council Bluffs 130
Florence 119
Sofia 119
Buffalo 117
Berlin 114
Da Nang 104
Palermo 97
Amman 94
Haiphong 93
São Paulo 86
Jinan 82
Shanghai 79
Verona 78
Guangzhou 74
Catania 73
Saint Petersburg 69
Shenyang 66
Dallas 61
Brescia 60
Chicago 60
Redondo Beach 60
Tappahannock 60
Modena 59
San Diego 59
Frankfurt am Main 58
Mülheim 57
Parma 56
Genoa 55
Nanchang 55
Changsha 52
Abidjan 50
Frattamaggiore 50
Tianjin 48
Phoenix 46
Reggio Emilia 46
Orem 44
San Francisco 43
Biên Hòa 41
Pescara 41
Redmond 41
Zhengzhou 41
Hải Dương 40
Trieste 40
Des Moines 39
Hangzhou 39
Falkenstein 38
Hebei 36
Can Tho 35
Dearborn 35
Rimini 35
Yubileyny 35
Mexico City 34
Cagliari 33
Mahé 33
Thái Nguyên 33
Bengaluru 32
Brussels 32
Nuremberg 32
Bangkok 31
Venice 30
Rio de Janeiro 29
Boydton 28
Totale 23.074
Salva come PNG Salva come JPEG
Nome #
Helicobacter pylori. Benedetto il giorno che ti ho incontrato 6.030
Nuovi orientamenti terapeutici per l’infezione da Helicobacter pylori: la terapia sequenziale. 1.092
Ruolo dei batteri componenti la flora intestinale nell’eziopatogenesi della colite ulcerosa e del cancro del colon: i Fusobatteri e il Bacteroides fragili enterotossico prendono la scena. 584
Sequenze genomiche dei batteri filamentosi segmentati negli animali da laboratorio. Implicazioni per la ricerca sull’uomo 388
Attuali criteri di terapia dell’infezione da Helicobacter pylori. New treatment of Helicobacter pylori infection 284
Change of point mutations in helicobacter pylori rRNA associated with clarithromycin resistance in Italy 270
Effetti avversi gastrointestinali: farmaci anti-infiammatori non steroidei ed Helicobacter pylori 237
Review article: Invasive and non-invasive tests for Helicobacter pylori infection 231
Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial 225
Accuracy of a new ultra fast rapid urease test to diagnose Helicobacter pylori infection in 1000 consecutive patients 223
Epidemiologia dell’Infezione da Helicobacter pylori e Cancro gastrico non cardiale. Insegnamenti per il futuro. 215
A validation study of the Italian Short-Form Leeds Dyspepsia Questionnaire 208
Diagnosi non invasiva e terapia per Helicobacter Pylori 206
A 10 days levofloxacin base triple therapy in patients who failed two eradication courses 205
A new 24 h ELISA culture based method for Helicobacter pylori chemosusceptibility 204
H. pylori antibiotic resistance and 13C urea breath test values. 202
Effects of Helicobacter pylori eradication on early-stage gastric mucosa associated lymphoid tissue lymphoma. 201
Effect of Proton Pump Inhibitors and Antacid Therapy on 13C-Urea Breath Tests and Stool Test for Helicobacter pylori Infection 200
A Rapid Immunochromatographic Assay for Helicobacter pylori in Stool before and after Treatment 199
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 199
Evolution of the use, effectiveness and safety of bismuth-containing quadruple therapy for Helicobacter pylori infection between 2013 and 2021: results from the European registry on H. pylori management (Hp-EuReg) 194
Cross-sectional study: CagA-positive helicobacter pylori infection, acute coronary artery disease and systemic levels of B-type natriuretic peptide 194
13C-urea breath test values and Helicobacter pylori eradication 194
E-test for Metronidazole Susceptibility Q1 in H pylori: Use of the Wrong Standard May Have Led to the Wrong Conclusion: Reply 192
Levofloxacin-based triple therapy for Helicobacter pylori retreatment: role of bacterial resistance. 192
Gastroesophageal Reflux Disease and Barrett’s Esophagus 189
Response to Dr Osato and Graham 188
Test rapido per la determinazione della chemiosensibilità dell'Helicobacter pylori 183
The Effects of Two Novel Copper-Based Formulations on Helicobacter pylori 182
Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy during 2010-2016 182
Tablet and oral liquid L-thyroxine formulation in the treatment of naive hypothyroid patients with Helicobacter pylori infection 181
Diagnosi dell’infezione da Helicobacter pylori 180
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 177
Management of helicobacter pylori infection-the Maastricht V/Florence consensus report 176
Phenotypic and genotype H. pylori Clarithromycin resistance and therapeutic outcomes: benefit and limits. 173
Nuove terapie per curare l’infezione da Helicobacter pylori 172
A human domain antibody and Lewisb–glyconjugate that inhibit binding of Helicobacter pylori to Lewisb receptor and inhibit bacterial adhesion to human gastric epithelium 172
Helicobacter pylori eradication: Are we really all equal? A controlled study in native and immigrant population 170
How useful is the rapid urease test for evaluating the success of Helicobacter pylori eradication therapy? 169
Therapy for H. pylori: Current concepts 169
Culture-based Selection Therapy for Patients Who Did Not Respond to Previous Treatment for Helicobacter pylori Infection 168
A comparison among three rapid urease tests to diagnose Helicobacter pylori infection in 375 consecutive dyspeptic 168
In vivo dissolution of levothyroxine soft gel capsules 168
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease 165
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 164
Cameron lesions: A still overlooked diagnosis. Case report and systematic review of literature 164
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 164
A novel stool PCR test for helicobacter pylori may predict clarithromycin resistance and eradication of infection at a high rate 161
Peptic ulcer and Helicobacter pylori. 159
Primary antibiotic resistance in Helicobacter pylori strains isolated in Northern and Central Italy. 159
Quantification of Serum Levels of Pepsinogens and Gastrin to Assess Eradication of Helicobacter Pylori 159
Role of compliance in Helicobacter pylori eradication treatment: Results of the European Registry on H. pylori management 158
Treatment of Helciobacter pylori infection 2014 158
Growth and adult height in atypical coeliac patients, with or without growth hormone deficiency. 158
Helicobacter pylori: current status and future prospects 157
Updating Primary Antibiotic Resistance in Helicobacter pylori Strains Isolated in Italy 156
Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review 156
The prevalence of celiac disease in children with type 1 diabetes mellitus increased in the mid nineties: an 18-yr longitudinal study based on anti-endomysial antibodies 156
Diagnosis of Helicobacter pylori: invasive and non- invasive tests 156
high Prevalence of Primary Antibiotic Resistance in Helicobacter pylori Isolates in Italy 154
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis 154
Accuracy of urea breath tests tablets after 10 minutes compared to standard 30 minutes to diagnose and monitoring Helicobacter pylori infection: a randomised controlled trial 152
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children. 152
An Atlas of Investigation and Management: HELICOBACTER PYLORI 151
Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. 150
Proton pump inhibitors and antiplatelet drugs in clinical cardiology. 150
A Systematic Review on Drugs Absorption Modifications after Eradication in Helicobacter pylori Positive Patients undergoing Replacement Therapy 149
Are Helicobacter Species and Enterotoxigenic Bacteroides fragilis Involved in Inflammatory Bowel Disease? 149
Diagnosi dell'infezione da Helicobacter pylori 147
The A2143G point mutation of Clarithromycin resistance affects H. pylori eradication 146
A combination of faecal tests for the detection of colon cancer: a new strategy for appropriate selection of referrals to colonoscopy ? A prospective multicenter italian study. 146
Global eradication rates for helicobacter pylori infection: systematic review and meta-analysis of sequantial therapy 145
Serological markers for gastric atrophy in asymptomatic subjects infected with Helicobacter pylori. 144
Probiotici ricombinanti e loro potenziale sulla salute umana 144
Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management 143
High Helicobacter pylori eradication with sequential therapy in elderly patients with peptic ulcer: a prospective controlled study 142
Helicobacter pylori and functional dyspepsia: an unsolved issue? 141
Twice daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomised controlled trial using standard and double doses of omeprazole within a triple therapy 141
Le molecole strutturali batteriche come potenziali candidate per l’evoluzione del concetto classico di probiotici. 141
La terapia gastroprotettiva nel paziente cardiopatico: un problema sempre attuale. 139
Recombinant probiotics and their potential in human health 139
Efficacy of 5-ASA in the treatment of colonic diverticular disease. 138
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and Meta-analysis of randomized controlled trials in adults and children 138
Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori 137
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains 137
Role of MIC levels of resistance to clarithromycin and metronidazole in Helicobacter pylori eradication 137
Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on Helicobacter pylori Management (Hp-EuReg) 136
Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg) 136
Treatment of Helicobacter Pylori in Latin America 136
Colonization by Helicobacter pylori of leprosy patients in Spain: immunomodulation to low molecular weight antigens of H pylori 136
Levofloxacin resistance and multi-drug resistant strains are prevalent in Italy. 133
Considerable use of furazolidone in Iran. 132
Valutazione di economia sanitaria sull’infezione da Helicobacter pylori. 132
Glaucoma and Helicobacter pylori: Eyes wide shut? 132
Letter: years of life that could be saved by preventing HCC 132
Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome 131
Sequential therapy for H. pylori: an “aberrant” therapy ready for general use. 131
Attuali criteri di terapia dell'infezione da Helicobacter pylori 130
High eradication rate with sequential therapy in naïve Helicobacter pylori patients with multi-resistant strains 130
Comparison of image analysis software packages in the assessment af adhesion of microorganism of mucosal epithelium using confocal laser scanning microscopy 129
Totale 24.048
Salva come PNG Salva come JPEG
Categoria #
all - tutte 116.183
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 116.183
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021525 0 0 0 0 0 0 0 0 0 0 0 525
2021/20222.935 308 81 181 295 292 137 60 219 91 92 706 473
2022/20233.143 317 376 185 343 170 237 129 184 588 143 316 155
2023/20243.401 482 336 191 291 187 292 170 130 145 361 429 387
2024/20259.979 555 1.065 607 672 1.984 694 963 631 496 541 355 1.416
2025/202615.359 1.439 1.204 1.532 1.254 1.639 920 1.171 1.123 2.595 1.234 711 537
Totale 42.035